Replies to post #182909 on Elite Pharmaceuticals Inc (ELTP)

[Jimmy Joe]

How time flies... valuation was done back in the fall of 2013. Thanks NASDAQ.
So back then Elites market cap was what? $29.95 million? In the fall of 2013 maybe slightly more.

So now Elite has a market cap of about 7.4 times that of when the valuation was done by an independent outfit.
And some here expect others to believe the value has declined?

ROTFLMMFAO!

[no2koolaid]

Two things...the completion of Elite's valuation was in November 2013 and market cap is not the same as valuation. But the premise is correct. Valuation is a point in time analysis. Consequently, the revenues, the successful P-3, the additional generics (I believe two), the additional infrastructure investments (the fluid bed dyer), and I believe one or two additional patents, would be added to the new valuation of Elite and support a higher range.

[Couch]

Two plus years now if memory serves me - and the standout is the addition of the phase 3 results and the market slowly moving towards mandating ADT opioids- I don't think that comes till 2018 - but the question I have is does a valuation take the political ADT climate in mind - I doubt it but it should.

Any way you slice it Elite is higher valued today then 2013.